Acuta Capital Partners as of March 31, 2018
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 55 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 14.0 | $86M | 5.9M | 14.61 | |
| Iovance Biotherapeutics (IOVA) | 12.3 | $75M | 4.5M | 16.90 | |
| Assembly Biosciences | 10.2 | $62M | 1.3M | 49.14 | |
| SPDR S&P Biotech (XBI) | 7.2 | $44M | 500k | 87.73 | |
| Ascendis Pharma A S (ASND) | 5.8 | $36M | 544k | 65.40 | |
| Argenx Se (ARGX) | 5.3 | $33M | 404k | 80.44 | |
| iShares Russell 2000 Index (IWM) | 5.0 | $30M | 200k | 151.84 | |
| Catalyst Biosciences | 4.9 | $30M | 1.2M | 25.80 | |
| Kadmon Hldgs | 4.1 | $25M | 6.0M | 4.25 | |
| Veracyte (VCYT) | 3.0 | $18M | 3.3M | 5.56 | |
| Intec Pharma | 2.8 | $17M | 2.7M | 6.32 | |
| Chembio Diagnostics | 2.6 | $16M | 2.0M | 8.00 | |
| PowerShares QQQ Trust, Series 1 | 2.2 | $14M | 85k | 160.14 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.1 | $13M | 1.8M | 7.21 | |
| Viewray (VRAYQ) | 1.9 | $12M | 1.9M | 6.43 | |
| IRIDEX Corporation (IRIX) | 1.9 | $11M | 2.0M | 5.72 | |
| Avexis | 1.2 | $7.4M | 60k | 123.58 | |
| Tandem Diabetes Care (TNDM) | 1.1 | $6.7M | 1.3M | 4.96 | |
| CAS Medical Systems | 1.1 | $6.6M | 5.2M | 1.26 | |
| Rocket Pharmaceuticals (RCKT) | 1.1 | $6.6M | 350k | 18.75 | |
| Eli Lilly & Co. (LLY) | 0.9 | $5.8M | 75k | 77.37 | |
| iShares MSCI Emerging Markets Indx (EEM) | 0.8 | $4.8M | 100k | 48.28 | |
| iShares FTSE/Xinhua China 25 Index (FXI) | 0.6 | $3.5M | 75k | 47.24 | |
| Cutera (CUTR) | 0.6 | $3.5M | 70k | 50.26 | |
| Mirati Therapeutics | 0.5 | $3.1M | 100k | 30.70 | |
| Fennec Pharmaceuticals (FENC) | 0.5 | $3.0M | 250k | 12.10 | |
| Armo Biosciences Ord | 0.5 | $3.0M | 80k | 37.41 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.5 | $2.9M | 3.0M | 0.96 | |
| United Therapeutics Corporation (UTHR) | 0.5 | $2.8M | 25k | 112.36 | |
| Nabriva Therapeutics | 0.5 | $2.8M | 560k | 5.03 | |
| Viveve Med | 0.4 | $2.5M | 685k | 3.66 | |
| 0.4 | $2.2M | 75k | 29.02 | ||
| Aerie Pharmaceuticals | 0.3 | $2.2M | 40k | 54.27 | |
| Editas Medicine (EDIT) | 0.3 | $1.8M | 55k | 33.16 | |
| Rockwell Medical Technologies | 0.3 | $1.6M | 305k | 5.21 | |
| Intellia Therapeutics (NTLA) | 0.3 | $1.6M | 75k | 21.09 | |
| Homology Medicines | 0.2 | $1.5M | 79k | 18.70 | |
| Tesaro | 0.2 | $1.4M | 25k | 57.16 | |
| Ra Pharmaceuticals | 0.2 | $1.4M | 270k | 5.31 | |
| Biotelemetry | 0.2 | $1.2M | 40k | 31.05 | |
| Accelr8 Technology | 0.2 | $1.1M | 50k | 22.86 | |
| Ampio Pharmaceuticals | 0.2 | $1.1M | 325k | 3.40 | |
| AMAG Pharmaceuticals | 0.2 | $1.0M | 50k | 20.16 | |
| Sangamo Biosciences (SGMO) | 0.2 | $950k | 50k | 19.00 | |
| Alimera Sciences | 0.2 | $1.0M | 974k | 1.03 | |
| OraSure Technologies (OSUR) | 0.1 | $845k | 50k | 16.90 | |
| Biosante Pharmaceuticals (ANIP) | 0.1 | $833k | 14k | 58.25 | |
| Nuvectra | 0.1 | $869k | 67k | 13.02 | |
| Glaukos (GKOS) | 0.1 | $617k | 20k | 30.85 | |
| Teva Pharmaceutical Industries (TEVA) | 0.1 | $427k | 25k | 17.08 | |
| Crispr Therapeutics (CRSP) | 0.1 | $457k | 10k | 45.70 | |
| Endo International (ENDPQ) | 0.1 | $356k | 60k | 5.93 | |
| Transenterix | 0.1 | $308k | 180k | 1.71 | |
| Mannkind (MNKD) | 0.1 | $302k | 133k | 2.28 | |
| Oncobiologics | 0.0 | $26k | 29k | 0.89 |
